Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06169735 · ClinicalTrials.gov registry record · Phase 4
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
A Phase 4 study of Adenoma and Parathyroid Dysfunction, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 417
- Enrollment target
- 1
- Study location
NCT06169735 is a Phase 4 study of Adenoma and Parathyroid Dysfunction that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 417 participants, below the 643-participant average among 6 other Adenoma trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06169735, a Phase 4 study of Adenoma and Parathyroid Dysfunction, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 417 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine if fluorescence with or without indocyanine green can facilitate safe and accurate thyroid and parathyroid surgery.
Conditions Studied
Interventions
- DRUG Indocyanine green
- DEVICE SPY Portable Handheld Imaging
Study Locations (1)
Alabama
- UAB Callahan Eye - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 417 participants |
| Start Date | 2024-04-11 |
| Est. Completion | 2026-05-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06169735
The ClinicalTrials.gov registry entry for NCT06169735 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 417 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 643-participant average among 6 other Adenoma trials with a reported enrollment target (35% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Adenoma appearing as the primary indexed condition, and to 2 interventions - of which Indocyanine green is the first listed.
NCT06169735 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT06169735 about?
NCT06169735 is a clinical study titled "Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation". The aim of this study is to determine if fluorescence with or without indocyanine green can facilitate safe and accurate thyroid and parathyroid surgery.
What is the current status of trial NCT06169735?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 417 participants. The study started on 2024-04-11. Estimated completion is 2026-05-01.
What conditions does trial NCT06169735 study?
This clinical trial studies the following conditions: Adenoma, Parathyroid Dysfunction.
What interventions are being tested in trial NCT06169735?
The interventions under investigation include: Indocyanine green (DRUG), SPY Portable Handheld Imaging (DEVICE).
Who is sponsoring clinical trial NCT06169735?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06169735 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adenoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
RECRUITING · Phase 1
-
Colorectal Cancer Screening in Cystic Fibrosis
ACTIVE NOT RECRUITING
-
CRC Detection Reliable Assessment With Blood
ACTIVE NOT RECRUITING
-
Polyp Prevention Trial
COMPLETED · Phase 3
-
Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy
COMPLETED · NA
-
Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal Times
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.